Emmanuel Compe Selected Research

Emmanuel Compe Research Topics

7	Trichothiodystrophy Syndromes 01/2021 - 11/2007
5	Xeroderma Pigmentosum (Kaposi's Disease) 01/2021 - 12/2009
3	Neoplasms (Cancer) 01/2021 - 02/2015
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2009 - 11/2007
1	Melanoma (Melanoma, Malignant) 01/2021
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 03/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2016
1	Skin Neoplasms (Skin Cancer) 08/2013
1	Microcephaly 11/2007
1	Congenital Hypothyroidism (Cretinism) 07/2007
1	Cockayne Syndrome (Syndrome, Cockayne) 04/2007
1	Necrosis 12/2004
1	Lipodystrophy 01/2002

5	Transcription Factor TFIIHIBA 01/2021 - 11/2007
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2013 - 04/2007
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	Liver X ReceptorsIBA 03/2020
1	CholesterolIBA 03/2020
1	transcription factor TFIIE (TFIIE)IBA 01/2019
1	RNA Polymerase II (RNA Polymerase B)IBA 10/2016
1	PM 01183IBA 10/2016
1	DNA (Deoxyribonucleic Acid)IBA 10/2016
1	UbiquitinIBA 10/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2016
1	Sirtuin 1IBA 10/2014
1	SulfurIBA 08/2013
1	CollagenIBA 03/2013
1	Phosphotransferases (Kinase)IBA 02/2011
1	A-Form DNA (A-DNA)IBA 11/2007
1	Hormones (Hormone)IBA 07/2007
1	Nelfinavir (Viracept)FDA Link 12/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2004
1	NucleosidesIBA 01/2002
1	Reverse Transcriptase InhibitorsIBA 01/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2002

2	Therapeutics 01/2021 - 10/2016
1	Highly Active Antiretroviral Therapy (HAART) 01/2002